Showing results (191-200 of 234) with videos related to
Sort By:
Pageof 24
Molecular Cell|July 2, 2019
lncRNA-Induced Spread of Polycomb Controlled by Genome Architecture, RNA Abundance, and CpG Island DNAMegan D Schertzer, Keean C A Braceros, Joshua Starmer, et al.The Journal of Allergy and Clinical Immunology|May 22, 2020
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosisKarin Hartmann, Jason Gotlib, Cem Akin, et al.Molecular Cell|March 21, 2025
Isogenic comparison of Airn and Xist reveals core principles of Polycomb recruitment by lncRNAsJackson B Trotman, Elizabeth W Abrash, McKenzie M Murvin, et al.American Journal of Hematology|March 15, 2016
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinibJorge E Cortes, H Jean Khoury, Hagop Kantarjian, et al.Haematologica|May 5, 2022
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemiaKathryn E Flynn, Ehab Atallah, Li Lin, et al.Leukemia & Lymphoma|October 25, 2019
Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE studyNeil P Shah, Valentín García-Gutiérrez, Antonio Jiménez-Velasco, et al.Hematology (Amsterdam, Netherlands)|October 7, 2025
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phaseEhab Atallah, Michael S Broder, Onyee Chan, et al.JAMA Network Open|December 18, 2023
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid LeukemiaAaron N Winn, Ehab Atallah, Jorge Cortes, et al.The New England Journal of Medicine|June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic MastocytosisJason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.The New England Journal of Medicine|November 30, 2012
Ponatinib in refractory Philadelphia chromosome-positive leukemiasJorge E Cortes, Hagop Kantarjian, Neil P Shah, et al.Pageof 24